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SUMMARY
Objectives. The aim of the study was to investigate cleft – affected tissues in children with 
cleft lip and palate in order to detect appearance of β-defensin, interleukins (IL) and gene proteins. 
Material and methods. The study group included 10 patients with cleft lip and palate. During 
nose surgery tissue samples from bone and cartilage have been taken, and stained with immunohis-
tochemistry for β-defensin 2, IL4, IL6, IL7, IL8, IL10 and MSX1, RYK, PAX9, IRF6 gene proteins. 
Results. Results showed prominent expression of IL10 (mean value 47.28±4.26 in visual fi eld) 
followed by IL7 (35.62±11.18) in cartilage of patients, but slightly less pronounced expression of IL8 
(30.14±8.74), IL6 (22.52±10.88) and IL4 (14.81±6.94). The expression of β-defensin 2 was prominent 
(34.52±11.79) and similar to expression of IL7 in tissue samples of cartilage. MSX1, PAX9, RYK and 
IRF6 (17.67±5.94; 16.14±5.52; 16.57±5.22 and 11.86±4.21) in cartilage was less pronounced than 
interleukins and β-defensin 2. MSX1 (12.44±3.34), PAX9 (6.89±2.14), RYK (11.0±5.92) and IRF6 
(9.1±4.76) gene proteins expression in bone showed mostly rare occurrence of positive structures. 
Conclusions. Signifi cant expression of IL7 and β-defensin 2 and IL10 in cartilage proves the 
prominent immune response in cleft affected hard tissue. Mostly indistinct MSX1, PAX9, RYK and 
IRF6 gene proteins expression in bone might be an indicator of not complete cellular differentiation, 
proliferation and migration events in cleft disordered hard tissue.
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INTRODUCTION
The most common craniofacial malformation 
worldwide in the newborn infants is the orofacial cleft, 
consisting of cleft lip with or without cleft palate and 
isolated cleft palate. These anomalies cause functional as 
well as esthetical disorders and decrease life quality for 
person. Cleft lip and palate affects approximately 1 of 
300 to 1 of 2500 live births, with wide variability across 
geographic origin, racial and ethnic groups (1). In Latvia 
cleft lip and palate occur in 1 of 700-800 live births what 
is average occurrence in Europe population (2).
Literature data suggests that etiology of cleft lip 
with or without cleft palate and isolated cleft palate are 
caused by primary defects in the fusion of craniofacial 
processes that form the primary and secondary palate 
and separates the nasal and oral cavities. Fusion and 
migration of primary palate takes place at about the 
fi fth or sixth week of embryonic life, whereas eleva-
tion and fusion of the secondary palate occurs at about 
six to eight weeks by a highly regulated process of 
mesenchymal proliferation and epithelial breakdown 
in three facial prominences: maxillary, the lateral nasal 
and medial nasal. Clefts of the palate can arise due to 
failure at any of several steps including palatal shelves 
elevation, migration, or fusion (3-5). 
This complicated process in craniofacial region 
are strongly caused, controlled and regulated by mul-
tiple factors, such as growth factors, cytokines and 
neuropeptides. Some genes and gene proteins are also 
essential for facial development, and in last decade 
there have been dozens of studies about identifi cation 
of genes or gene proteins that maybe responsible for 
skeletal anomalies and gene inactivation both in mouse 
and humans (6, 7). In general, it has been proposed 
that their differential expression controls patterning 
of the facial structures. 
Family of homeobox genes is important in es-
tablishing of craniofacial, axial and appendicular 
skeletal pattern. Msx1 (Msh homeobox 1) is member 
of homeobox gene family and are widely expressed 
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in many organs. It may have important role in limb 
formation, craniofacial development, odontogenesis, 
and tumor growth inhibition. Mutations in the MSX1 
gene may be associated in the pathogenesis of cleft lip 
and palate (8, 9). RYK gene belongs to a subclass of 
catalytically inactive, but otherwise distantly related, 
receptor protein tyrosine kinases (RTKs) and is es-
sential for normal development and morphogenesis of 
craniofacial structures including the secondary palate 
(10). Recent studies also showed evidence of paired 
box gene 9 or PAX9 gene association in development 
of mammal dentition and nonsyndromic cleft lip 
with or without cleft palate (11), as well as IRF 6 or 
interferon regulatory factor 6 that could be related to 
development and formation of palate (12). 
β-defensin 2 also known as skin-antimicrobial 
peptide 1 (SAP1) is a antibiotic peptide which is locally 
regulated by infl ammation. β-defensin 2 is produced by 
epithelial cells and are expressed in all human epithelial 
tissues. In the oral cavity, the tissues that contain human 
β-defensins include: gingiva, tongue, salivary glands, 
and mucosa and has antimicrobial activity (13, 14). 
Secreted proteins that bind to their specifi c re-
ceptors and play a role in the communication among 
leukocytes are named interleukins (IL). Although IL 
are a type of cytokines that have immunomodulatory 
functions-including cell proliferation, maturation, 
migration and adhesion, these cytokines also play an 
important role in subjects with non-syndromic cleft lip 
and palate in cross-talk between IL6 and transforming 
growth factor-beta 3 through regulation of extracellular 
matrix production by human fi broblasts. IL4 has been 
called the prototypic immunoregulatory cytokine and 
has an important role in regulating antibody produc-
tion, hematopoiesis and infl ammation, and the develop-
ment of effector T-cell responses. IL6 has been mostly 
regarded as a pro-infl ammatory cytokine but has many 
regenerative or anti-infl ammatory activities. IL8 was 
identifi ed as a neutrophil-specifi c chemotactic factor 
and later classifi ed as a member of the 
CXC chemokine family. The major effector 
functions of IL8 are activation and recruit-
ment of neutrophils to the site of infection 
or injury. Increased concentrations of IL8 
were found in infl ammatorysites in patients 
with diseases such as psoriasis and chronic 
obstructive pulmonary diseases. Interleukin 
7 (IL7) plays a central, critical role in the 
homeostasis of the immune system and it 
is important in B and T cell development. 
Human interleukin 10 (IL10) is a potent 
anti-infl ammatory cytokine that inhibits 
the synthesis of the major proinfl ammatory 
cytokines and chemokines (15, 16).
The aim of study was to investigate cleft-affected 
tissues in children with cleft lip and palate in order to 
detect appearance of β-defensin 2, IL4, IL6, IL7, IL8, 
IL10 and MSX1, RYK, PAX9, IRF6 gene proteins. 
MATERIALS AND METHODS
Preliminary study group included totally 10 pa-
tients with cleft lip and palate in the age from 7 to 10 
years with mean age 8.6±1.03 years. Biopsy samples 
from cartilage and bone were taken during nose surgery 
at the Cleft Lip and Palate Centre of the Institute of 
Stomatology of Riga Stradins University. The study 
protocol was approved by the ethics committee of Riga 
Stradins University in May 2003. 
Standard biotine and streptovidine immunohis-
tochemical method (17) was used for the detection 
of gene proteins, β-defensin 2 and interleukins. The 
tissues samples were fi xed in 2% formaldehyde and 
0.2% picric acid in 0.1 M phosphate-buffer (pH 7.2). 
After that procedure they were washed in phosphate-
buffered saline containing 10 % sacharose for 12 hours, 
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Fig. 1. Microphotograph of abundant IL10 containing cells in 
cartilage of cleft lip and palate patient, IMH, ×100.
Table 1. Marking of relative frequency of immunohistochemically deter-




0 No positive structures in the visual fi eld
0/+ Rare occurance of positive structures in the visual fi eld
+ Few positive structures in the visual fi eld
+/++ Few to moderate number of positive structures in the visual 
fi eld
++ Moderate number of  positive structures in the visual fi eld
++/+++ Moderate to numerous positive structures  in the visual fi eld
+++ Numerous positive structures in the visual fi eld
+++/++++ Plenty of positive structures in the visual fi eld
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embedded in paraffi n, and cut into 6-7 μm thick sec-
tions. After deparaffi nization slides were stained with 
biotin-streptavidin immunohistochemical method to 
detect presence of gene proteins MSX1 (orb18823, 
1:100, Biorbyt Ltd., UK), IRF6 (ab167403, 1:100, 
Abcam, UK), PAX9 (orb120466, 1:100, Biorbyt Ltd., 
UK), RYK (orb38371, 1:100, Biorbyt Ltd., UK), 
β-defensin 2 (af27580, 1:100, RD Systems, UK), and 
interleukins IL4 (orb10908, 1:100, Biorbyt Ltd., UK), 
IL6 (sc130326, 1:50, Santa Cruz Biotechnology, USA), 
IL7 (orb48420, 1:100, Biorbyt Ltd., UK), IL8 (sc1269, 
1:50, Santa Cruz Biotechnology Inc., USA), and IL10 
(ab34843, 1:400, Abcam, UK). 
To record the relative frequency of indices de-
tected by the immunohistochemical method, a semi-
quantitative counting method widely used in the lit-
erature was employed (18). The appearance frequency 
of factors was analyzed in three visual fi elds of each 
section (Table 1). 
The data were analyzed using descriptive and 
analytical statistical methods. Counting of positive cells 
per 3 visual fi elds and calculation of mean value and 
standard deviation performed semi-quantative analysis 
of the slides. 
RESULTS
Analysis of the appearance of 
the studied gene proteins, inter-
leukins and β-defensin in the bone 
and cartilage in cleft lip and palate 
patients revealed that the presence 
of these biological markers is rather 
variable (Tables 2, 3).
From all biological markers used 
in this study the most prominent was 
the expression of IL10 (mean value 
47.28±4.26) and IL7 (mean value 
35.62±11.18) in cartilage of patients 
with cleft lip and palate (Figures 1, 
2), but slightly less pronounced ex-
pression of IL8 (mean value 30.14±8.74), IL6 (mean 
value 22.52±10.88) and IL4 (mean value 14.81±6.94). 
In few cases tissue samples revealed plenty of positive 
structures in zone of proliferating cartilage with almost 
lack or few positive structures in other parts of sample 
(Fig. 3). Mainly expression of interleukins was evenly 
distributed, but in some cases appearance of positive 
structures was uneven, especially in expression of 
IL4 (Fig. 4). We observed signifi cant expression of 
β-defensin 2 (mean value 34.52±11.79) in cartilage with 
numerous and/or abundance of positive structures in the 
visual fi eld also (Fig. 5). Appearance of MSX1 (mean 
value 17.67±5.94), PAX9 (mean value 16.14±5.52), 
RYK (mean value 16.57±5.22) and IRF6 (mean value 
11.86±4.21) was less pronounced than interleukins and 
β-defensin 2 and varied from occasional to numerous 
positive structures in the visual fi eld in some patients 
but majority of samples revealed moderate number of 
positive structures in visual fi eld (Figures 6, 7). 
Tissue samples obtained from 3 cleft lip and palate 
patients were stained to detect appearance of MSX1 (mean 
value 12.44±3.34), PAX9 (mean value 6.89±2.14), RYK 
(mean value 11±5.92) and IRF6 (mean value 9.11±4.76) 
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Patient Nr. IL4 IL6 IL7 IL8 IL10 MSX1 PAX9 RYK IRF6 β-defensin2
1. ++/+++ ++ ++ ++ +++/++++ ++ ++ +++ ++ +++/++++
2. +++/++++ +++/++++ +++/++++ +++ +++/++++ ++ 0/+ ++ + +++
3. ++ +++ +++ ++/+++ +++ +/++ + ++ ++ +++/++++
4. +/++ +++ +++/++++ ++ +++/+++++ + + ++ 0/+ +++/++++
5. +++ +++/++++ +++/++++ +++/++++ +++ +++ ++ +++ ++ +++/++++
6. +/++ +++/++++ +++/++++ +++/++++ +++/++++ +++ +++ +++ ++/+++ +++/++++
7. +++ +++/++++ +++ +++/++++ +++/++++ +++ +++ ++/+++ ++ +++/++++
0 – no positive structures in the visual fi eld, 0/+ – occasional occurance of positive structures in the visual fi eld, + – few 
positive structures in the visual fi eld, +/++ – few to moderate number of positive structures in the visual fi eld, ++ – moder-
ate number of  positive structures in the visual fi eld, ++/+++ – moderate to numerous positive structures  in the visual fi eld, 
+++ – numerous positive structures in the visual fi eld, +++/++++ – abundance of positive structures in the visual fi eld.
Table 2. Semiquantitative distribution of immunoreactive structures in the cartilage of patients with cleft lip and palate
Fig. 2. Mean numbers and standard deviations of immunoreactive cells in cartilage 
of patients with cleft lip and palate.
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gene proteins expression in bone (Fig. 8) and showed 
mostly rare occurrence of positive structures in the visual 
fi eld in exception of RYK gene protein that showed from 
few to moderate positive structures in visual fi eld. 
Two patients showed rather similar MSX1, PAX9, 
RYK and IRF6 gene protein expression that varied 
from no positive structures to moderate positive 
structures in visual fi eld but one patient showed more 
pronounced gene protein expression. Interestingly 
that MSX1 and PAX9 expression in mature bone and 
periosteum differs sig-
nifi cantly in all tissue 
samples. 
In bone we saw 
occasional occurrence 
of positive structures in 
visual fi eld but in peri-
osteum mainly moder-
ate to numerous posi-
tive structures in visual 
fi eld. That was not the 
case in expression of 
RYK and IRF6. Appearance of positive structures in 
bone and periosteum was distributed evenly. There was 
no difference between patients and all of them showed 
similar expression of these gene proteins. 
DISCUSSION
In our study appearance of MSX1 and PAX9 was 
less pronounced than interleukins and β-defensin 2 in car-
tilage, as well as in bone and majority of samples revealed 
Patient 
Nr.
MSX1 PAX9 RYK IRF6
Bone Periosteum Bone Periosteum Bone Periosteum Bone Periosteum
8. 0/+ +++ + ++/+++ +++ +++ +++ +++
9. + +++ 0/+ 0/+ ++ ++ 0 0/+
10. 0/+ ++ 0/+ + +/++ +/++ 0/+ 0/+
0 – no positive structures in the visual fi eld, 0/+ – rare occurrence of positive structures in the 
visual fi eld, + – few positive structures in the visual fi eld, +/++ – few to moderate number of 
positive structures in the visual fi eld, ++ – moderate number of  positive structures in the visual 
fi eld, ++/+++ – moderate to numerous positive structures  in the visual fi eld, +++ – numerous 
positive structures in the visual fi eld, +++/++++ – plenty of positive structures in the visual fi eld.
Table 3. Semiquantitative distribution of immunoreactive structures in the bone of patients with 
cleft lip and palate
Fig. 3. Microphotograph of IL7 positive cells, especially in 
proliferation zone of cartilage of cleft lip and palate patient, 
IMH, ×200
Fig. 5. Microphotograph of abundant β-defensin 2 immu-
noreactive cells in cartilage of cleft lip and palate patient, 
IMH, ×200
Fig. 4. Microphotograph of uneven appearance of IL4 
positive structures in cartilage of cleft lip and palate patient, 
IMH, ×100
Fig. 6. Microphotograph of moderate MSX1 immunoreactive 
cells in cartilage of cleft lip and palate patient, IMH, ×200
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tion to cleft lip and palate but there are some studies 
indicating that IRF6 is involved in the development of 
cleft lip and palate also (24). Kondo et al. (25) prelimi-
nary fi ndings in mice have revealed IRF6 expression 
in the medial edge epithelia of fusing secondary palatal 
shelves, tooth buds, hair follicles, and skin. In this study 
RYK and IRF6 expression showed mostly rare occur-
rence of positive structures in the visual fi eld and was 
downregulated in cartilage and bone that could indicate 
involvement in the pathogenesis of cleft lip and palate. 
β-defensin 2 was the second most evident biological 
marker stained for immunochemistry in our study and in 
almost all cases we observed plenty of positive structures 
in visual fi eld. Human beta-defensins represent a major 
subclass of antimicrobial peptides and act as a fi rst line 
of defense through their broad spectrum of potent anti-
microbial activity. β-defensin 2 could be found in many 
infl ammatory diseases, for example, periodontitis, peri-
implantitis and osteoarthritis (23). Varoga et al. (26) in his 
study demonstrated that samples of osteomielitis infected 
bone produce higher levels of endogenous antibiotics, 
such as human beta-defensin-2, when compared with 
samples of healthy bone. Our results proves the promi-
nent immune response in cleft affected hard tissue This 
scientifi c information about β-defensin 2 in relation to our 
study may suggest that tissues from patients with cleft 
lip and palate are infl amed and could infl uence healing 
process after surgery. 
IL4, IL10 are a well know anti-infl ammatory and 
immunoregulatory cytokines, mainly released by, and 
acting on cells of the immune system such as monocytes, 
macrophages and T cells. IL10 is also produced by a few 
connective tissue cell types including chondrocytes and is 
involved in processes such as connective tissue extracel-
lular matrix remodeling (27). IL7 stimulates production 
of proteases by IL7 receptor-expressing chondrocytes and 
enhances cartilage matrix degradation (28). DeBenedetti 
at al. (29) mentioned that mice transgenic for the infl am-
moderate number of positive structures in visual fi eld. 
Clinically patients in our study had missing teeth (mostly 
upper lateral incisors) and microdontia. Dental anomalies 
in cleft lip and palate patients, such as missing teeth, 
supernumerary teeth, microdontia, taurodontism and 
transposition and/or ectopic teeth and hipoplastic teeth, 
are found frequently (19). In literature data we can see 
strong evidence that these dental anomalies are associated 
with some gene mutations, for example MSX1 and PAX9. 
Both genes are coexpressed in dental mesenchyme and 
appear critical for tooth morphogenesis, because in Msx1 
and Pax9 homozygous null mutants, tooth organs arrest at 
the bud stage (20, 21). Nacatomi at al. (22) reported that 
a combined reduction of PAX9 and MSX1 gene dosage 
in humans may increase the risk for orofacial clefting and 
oligodontia and Msx1 and Pax9 interact synergistically 
throughout lower incisor development and affect multiple 
signaling pathways that infl uence incisor size and sym-
metry. Results from our study prove MSX1 and PAX9 
involvement in tooth morphogenesis and development 
of cleft lip and palate. Msx1 acts as a modeling factor 
for membranous bone also. It stimulates trabecular bone 
metabolism but limits cortical bone growth by promoting 
apoptosis, and concomitantly controls the collagen-based 
mineralization process (23). Indistinct MSX1 and PAX9 
gene proteins expression in bone could be an indicator 
of not complete cellular differentiation, proliferation and 
migration events in cleft disordered hard tissue.
While no specifi c disease-causing gene mutations 
have been identifi ed in non-syndromic clefting, a dozens 
of candidate genes have been isolated and RYK is one 
of them. Halford et al. (10) demonstrate that the mouse 
orphan receptor ‘related to tyrosine kinases’ (Ryk) is 
essential for normal development and morphogenesis 
of craniofacial structures including the secondary palate 
and mouse embryos defi cient in RYK have craniofacial 
defects, for instance complete clefts of the secondary 
palate. IRF6 has not been widely studied in the connec-
Fig. 7. Microphotograph of moderate PAX9 
immunoreactive cells in cartilage of cleft lip 
and palate patient, IMH, ×200
Fig. 8. Mean numbers and standard deviations of immunoreactive cells in bone 
of patients with cleft lip and palate
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matory cytokine interleukin-6, expressing high circulat-
ing levels of IL6 since birth, show a marked decrease 
in growth rate leading to adult mice 50–70% the size of 
wild-type littermates. In our study signifi cant appearance 
of IL7 and IL10 was seen in cartilage of patients with cleft 
lip and palate, but slightly less pronounced expression of 
IL4, IL6 and IL8, pointing that patient with cleft lip and 
palate presents disorders in immune response. 
CONCLUSION
The most prominent was the expression of IL10 
in tissue samples of cartilage with numerous and/or 
plenty of positive structures in the visual fi eld and 
signifi cant expression of IL7 and β-defensin 2, but 
slightly less pronounced expression of IL4, IL6 and 
IL8. Signifi cant expression of IL10 and β-defensin 
2 and IL7 in cartilage proves the prominent immune 
response in cleft affected hard tissue. Mostly indistinct 
MSX1, PAX9, RYK and IRF6 gene proteins expression 
in bone might be an indicator of not complete cellular 
differentiation, proliferation and migration events in 
cleft disordered hard tissue.
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